Literature DB >> 15778512

The mdr1a-/- mouse model of spontaneous colitis: a relevant and appropriate animal model to study inflammatory bowel disease.

Jacque N Wilk1, Janine Bilsborough, Joanne L Viney.   

Abstract

There are many types of colitis models in animals that researchers use to elucidate the mechanism of action of human inflammatory bowel disease (IBD). These models are also used to test novel therapeutics and therapeutic treatment regimens. Here, we will review the characteristics of the mdr1a -/- model of spontaneous colitis that we believe make this model an important part of the IBD researcher's toolbox. We will also share new data that will reinforce the fact that this model is relevant in the study of IBD. Mdr1a -/- mice lack the murine multiple drug resistance gene for P-glycoprotein 170 that is normally expressed in multiple tissues including intestinal epithelial cells. These mice spontaneously develop a form of colitis at around 12 wk of age. The fact that the complexity of this model mirrors the complexity of disease in humans, as well as recent literature that links MDR1 polymorphisms in humans to Crohn's Disease and Ulcerative Colitis, makes this an appropriate animal model to study.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15778512     DOI: 10.1385/IR:31:2:151

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  37 in total

Review 1.  Crohn's disease.

Authors:  Fergus Shanahan
Journal:  Lancet       Date:  2002-01-05       Impact factor: 79.321

2.  mdr1a-encoded P-glycoprotein is not required for peripheral T cell proliferation, cytokine release, or cytotoxic effector function in mice.

Authors:  M D Eisenbraun; R A Miller
Journal:  J Immunol       Date:  1999-09-01       Impact factor: 5.422

Review 3.  The central role of chemokines (chemotactic cytokines) in the immunopathogenesis of ulcerative colitis and Crohn's disease.

Authors:  R P MacDermott; I R Sanderson; H C Reinecker
Journal:  Inflamm Bowel Dis       Date:  1998-02       Impact factor: 5.325

Review 4.  Role of cytokines in the pathogenesis of inflammatory bowel disease.

Authors:  K A Papadakis; S R Targan
Journal:  Annu Rev Med       Date:  2000       Impact factor: 13.739

5.  Differential overexpression of three mdr gene family members in multidrug-resistant J774.2 mouse cells. Evidence that distinct P-glycoprotein precursors are encoded by unique mdr genes.

Authors:  S I Hsu; L Lothstein; S B Horwitz
Journal:  J Biol Chem       Date:  1989-07-15       Impact factor: 5.157

Review 6.  Mucosal IL-7-mediated immune responses in chronic colitis-IL-7 transgenic mouse model.

Authors:  M Watanabe; Y Ueno; M Yamazaki; T Hibi
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

7.  Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells.

Authors:  M B Dwinell; N Lügering; L Eckmann; M F Kagnoff
Journal:  Gastroenterology       Date:  2001-01       Impact factor: 22.682

8.  Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation.

Authors:  M C Kullberg; A G Rothfuchs; D Jankovic; P Caspar; T A Wynn; P L Gorelick; A W Cheever; A Sher
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

9.  Differences in P-glycoprotein-170 expression and activity between Crohn's disease and ulcerative colitis.

Authors:  B Yacyshyn; W Maksymowych; M B Bowen-Yacyshyn
Journal:  Hum Immunol       Date:  1999-08       Impact factor: 2.850

10.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

View more
  24 in total

Review 1.  Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy.

Authors:  David S Miller; Björn Bauer; Anika M S Hartz
Journal:  Pharmacol Rev       Date:  2008-06-17       Impact factor: 25.468

Review 2.  Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies.

Authors:  Iurii Koboziev; Fridrik Karlsson; Songlin Zhang; Matthew B Grisham
Journal:  Inflamm Bowel Dis       Date:  2011-02-10       Impact factor: 5.325

Review 3.  Proteomics in Inflammatory Bowel Disease: Approach Using Animal Models.

Authors:  Fadi H Mourad; Yunki Yau; Valerie C Wasinger; Rupert W Leong
Journal:  Dig Dis Sci       Date:  2017-07-17       Impact factor: 3.199

Review 4.  Animal models of inflammatory bowel disease: a review.

Authors:  Nidhi Goyal; Ajay Rana; Abhilasha Ahlawat; Krishna Reddy V Bijjem; Puneet Kumar
Journal:  Inflammopharmacology       Date:  2014-06-07       Impact factor: 4.473

5.  Contribution of genetics to a new vision in the understanding of inflammatory bowel disease.

Authors:  A S Peña
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

6.  Influence of MDR1 polymorphism on H. pylori-related chronic gastritis.

Authors:  Tomomitsu Tahara; Tomoyuki Shibata; Hiromi Yamashita; Ichiro Hirata; Tomiyasu Arisawa
Journal:  Dig Dis Sci       Date:  2010-05-13       Impact factor: 3.199

Review 7.  Is the sugar always sweet in intestinal inflammation?

Authors:  Emiko Mizoguchi; Atsushi Mizoguchi
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

8.  Differential susceptibility of P-glycoprotein deficient mice to colitis induction by environmental insults.

Authors:  Elizabeth M Staley; Trenton R Schoeb; Robin G Lorenz
Journal:  Inflamm Bowel Dis       Date:  2009-05       Impact factor: 5.325

Review 9.  Inflammatory bowel disease: review from the aspect of genetics.

Authors:  Shunji Ishihara; M M Aziz; Takafumi Yuki; Hideaki Kazumori; Yoshikazu Kinoshita
Journal:  J Gastroenterol       Date:  2009       Impact factor: 7.527

10.  Intestinal P-glycoprotein exports endocannabinoids to prevent inflammation and maintain homeostasis.

Authors:  Rose L Szabady; Christopher Louissaint; Anneke Lubben; Bailu Xie; Shaun Reeksting; Christine Tuohy; Zachary Demma; Sage E Foley; Christina S Faherty; Alejandro Llanos-Chea; Andrew J Olive; Randall J Mrsny; Beth A McCormick
Journal:  J Clin Invest       Date:  2018-08-13       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.